EUVIMEDEUVIMED entdecken
Crossref

Effects of G-CSF and 5-FU as conditioning regimens in platelet-targeted gene therapy for hemophilia B

Wenjue Xu, Huiyan Han, Binbin Li, Rui Huang, Qing Lin, Guowei Zhang

Blood Cells, Molecules, and Diseases · 2026

DOI: 10.1016/j.bcmd.2025.102965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2026. Verfasst von Wenjue Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key laboratory of Medical Epigenetics, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China. Hauptthemen laut MEDLINE: Genetic Therapy, Hemophilia B, Fluorouracil, Blood Platelets. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelet-targeted gene therapy for hemophilia entails modifying a patient's hematopoietic stem cells (HSCs) ex vivo to produce platelets containing coagulation factors, offering a potential cure by localized factor release at injury sites. However, the associated bone marrow transplantation carries significant risks, underscoring the critical need for low-toxicity conditioning regimens to enable clinical translation. This study evaluated G-CSF and 5-FU as conditioning regimens to facilitate the engraftment of HSCs expressing platelet-targeted FIX Padua. Hemophilia B (HB) mice were conditioned with G-CSF, 5-FU alone, or a combination of G-CSF, plerixafor, and 5-FU. Bone marrow mononuclear cells (BM-MNCs) from transgenic donors (2bF9-R338L) expressing platelet-stored FIX Padua were transplanted. G-CSF conditioning enabled long-term engraftment with 1 × 108 BM-MNCs; however, the efficacy declined significantly with lower cell doses. A single-dose of 5-FU (150 mg/kg) administered one day pre-transplant achieved optimal FIX expression and minimal toxicity. Critically, a combined regimen of G-CSF/plerixafor plus timed 5-FU (day -1) yielded stable, long-term platelet FIX expression and phenotypic rescue. The success of 5-FU underscores the importance of creating a transient niche vacancy for donor HSC engraftment. These results demonstrate that this mobilization-based, non-myeloablative conditioning strategy is a promising approach for platelet-targeted gene therapy for hemophilia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyHemophilia BFluorouracilBlood PlateletsTransplantation ConditioningGranulocyte Colony-Stimulating FactorAnimalsMiceFactor IXHematopoietic Stem Cell TransplantationMice, TransgenicHumansDisease Models, Animal

Stichwörter der Autor:innen

5-FUBone marrow transplantationG-CSFGene therapyHemophilia B

Substanzen

FluorouracilGranulocyte Colony-Stimulating FactorFactor IX

Autor:innen und Institutionen

  • Zhejiang Key laboratory of Medical Epigenetics, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China.
  • Lingyi Biotech Co., Ltd., Hangzhou, China.
  • Zhejiang Key laboratory of Medical Epigenetics, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China. Electronic address: gzhang@hznu.edu.cn.

Zitieren

APA

Xu, W., Han, H., Li, B., Huang, R., Lin, Q., & Zhang, G. (2026). Effects of G-CSF and 5-FU as conditioning regimens in platelet-targeted gene therapy for hemophilia B. Blood Cells, Molecules, and Diseases. https://doi.org/10.1016/j.bcmd.2025.102965

Vancouver

Xu W, Han H, Li B, Huang R, Lin Q, Zhang G. Effects of G-CSF and 5-FU as conditioning regimens in platelet-targeted gene therapy for hemophilia B. Blood Cells, Molecules, and Diseases. 2026. doi:10.1016/j.bcmd.2025.102965

BibTeX
@article{Xu2026,
  author = {Xu, Wenjue and Han, Huiyan and Li, Binbin and Huang, Rui and Lin, Qing and Zhang, Guowei},
  title = {Effects of G-CSF and 5-FU as conditioning regimens in platelet-targeted gene therapy for hemophilia B},
  journal = {Blood Cells, Molecules, and Diseases},
  year = {2026},
  doi = {10.1016/j.bcmd.2025.102965}
}
Kostenlos starten →